Clinical, electrocardiographic, and echocardiographic parameters associated with the development of pacing and implantable cardioverter-defibrillator indication in patients with transthyretin amyloid cardiomyopathy.
Yusei KawaharaHisanori KanazawaSeiji TakashioYuichiro TsurutaHitoshi SumiTakuya KiyamaShozo KanekoMiwa ItoTadashi HoshiyamaKyoko HirakawaMasanobu IshiiNoriaki TabataKenshi YamanagaKoichiro FujisueShinsuke HanataniDaisuke SuetaYuichiro ArimaSatoshi ArakiHiroki UsukuTaishi NakamuraEiichiro YamamotoHirofumi SoejimaKenichi MatsushitaHiroaki KawanoKenichi TsujitaPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
According to our retrospective single-center observational study, prophylactic PDI did not require first-degree AV block in both ATTRwt-CM and ATTRv-CM patients, and prophylactic ICD implantation was also controversial in both ATTR-CM. Larger prospective, multi-center studies are necessary to confirm these results.